XML 30 R17.htm IDEA: XBRL DOCUMENT v3.22.1
SHARE-BASED COMPENSATION
12 Months Ended
Dec. 31, 2021
SHARE-BASED COMPENSATION  
SHARE-BASED COMPENSATION

10.SHARE-BASED COMPENSATION

Stock Options

As of December 31, 2021, there were 105,845 and 226,164 shares of common stock available for future grants under the Company's 2013 Stock Incentive Plan and 2021 Stock Incentive Plan, respectively.

The following assumptions were used to estimate the fair value of stock options granted using the Black-Scholes-Merton option pricing model during the years ended December 31:

    

2021

    

2020

 

Assumptions:

 

  

 

  

Risk-free interest rate

 

0.47% – 0.66

%

0.30% – 1.41

%

Expected term (in years)

 

5.81 – 5.89

 

5.32 – 6.14

Expected volatility

 

49.83% –49.98

%

43.11% – 50.14

%

Expected dividend yield

 

%

%

A summary of stock option activity under the 2013 Stock Incentive Plan and 2021 Stock Incentive Plans is as follows:

Weighted Average 

Remaining 

 

Options

Weighted Average

Contractual Term 

 

Aggregate

    

Outstanding

    

Exercise Price

    

in Years

    

Intrinsic Value

Balance at January 1, 2019

224,884

$

1.08

8.78

$

Granted

43,259

1.00

Exercised

1.00

Cancelled/forfeited

(16,296)

4.20

Balance at December 31, 2020

 

251,847

$

1.00

 

8.06

$

89,100

Granted

 

70,164

5.74

 

9.34

432,520

Exercised

 

(55,694)

1.00

 

379,276

Cancelled/forfeited

 

(11,170)

1.00

 

Balance at December 31, 2021

 

255,147

$

2.32

 

7.75

$

1,550,409

Options exercisable at December 31, 2021

 

179,711

$

1.12

 

7.04

$

1,219,964

The aggregate intrinsic value in the table above represents the difference between the Company's stock price as of the balance sheet date and the exercise price of each in-the-money option on the last day of the period. The total intrinsic value of stock options exercised was approximately $379,276 and $0 and during the year ended December 31, 2021 and 2020, respectively.

The weighted-average grant date fair value of stock options issued in the years ended December 31, 2021 and 2020 was $3.94 and $0.55, respectively. The Company recorded compensation expense as follows for years ended December 31, 2021 and 2020:

     

2021

     

2020

Operating expenses:

 

  

  

General and administrative

$

257,005

$

38,367

Sales and marketing

55,035

8,216

Fulfillment

41,482

6,193

Supply development

 

8,138

1,215

Technology

 

260,404

38,875

Total

$

622,064

$

92,866

A total of $432,520 of unamortized compensation expense at December 31, 2021, will be recognized over the remaining requisite service period of 2.4 years. During 2021 and 2020, the Company received proceeds of $58,648 and $0 from the exercise of stock options, respectively.

2021 Stock Incentive Plan

On June 16, 2021, the Company adopted the iSpecimen Inc. 2021 Stock Incentive Plan (“the 2021 Plan”). The 2021 Plan was adopted to enhance our ability to attract, retain and motivate employees, officers, directors, consultants and advisors by providing such persons with equity ownership opportunities and performance-based incentives. The 2021 Plan authorizes options, restricted stock, restricted stock units and other stock-based awards. The Company's Board of Directors, or any committee to which the Board of Directors delegates such authority, has the sole discretion in administering, interpreting, amending or accelerating the 2021 Plan. Awards may be made under the 2021 Plan for up to 608,000 shares of the Company's common stock, and the 2021 Plan was made effective with the completion of the IPO. During the year ended December 31, 2021, 381,836 equity awards were issued from the 2021 Plan.

Restricted Stock Units

During the year ended December 31, 2021, the Company granted 127,350 restricted stock units to employees, resulting in recognition of the following expense :

2021

Operating expenses:

General and administrative

$

6,453

Fulfillment

21,824

Sales and marketing

25,686

Supply development

13,304

Technology

18,290

Total

$

85,557

These restricted stock units are subject to one-year cliff vesting, with 25% of the restricted stock units vesting on the first anniversary of issuance. The remaining restricted stock units vest quarterly over a three-year period. As of December 31, 2021, unrecognized stock-based compensation expense related to the unvested employee restricted stock units was $845,933 which the Company expects to recognize on a straight-line basis over a weighted average period of approximately 3.52 years.

During July 2021, the Company granted 189,396 restricted stock units to members of the executive team, resulting in expense of $394,555 recorded in general and administrative expense and technology. These restricted stock units are subject to a four year vesting period, with 20% of the units vesting immediately upon issuance. The remaining restricted stock units vest annually over a four-year period. As of December 31, 2021, unrecognized stock-based compensation expense related to the unvested restricted stock units was $806,216 which the Company expects to recognize on a straight-line basis over a weighted average period of approximately 3.47 years.

During July 2021, the Company granted 12,500 restricted stock units to board directors, resulting in expense of $33,121 recorded in general and administrative expense and technology. These restricted stock units vest quarterly over a one-year period. As of December 31, 2021, unrecognized stock-based compensation expense related to these unvested restricted stock units was $45,379 which the Company expects to recognize on a straight-line basis over a weighted average period of approximately 0.50 years.

During the year ended December 31, 2020, no restricted stock units were granted by the Company, nor were there any outstanding.

Options

Weighted Average Grant

    

Outstanding

Date Fair Value

Unvested Balance at December 31, 2020

 

$

Granted

 

329,246

6.71

Vested

 

(44,129)

6.33

Forfeited

 

(2,700)

6.34

Unvested Balance at December 31, 2021

 

282,417

$

6.78

Performance Stock Units

During July 2021, the Company issued 47,349 performance stock units to four members of the executive team pursuant to each executive's employment agreement executed in connection with the IPO. The performance stock units are subject to certain performance conditions relating to certain revenue and cost of revenue metrics to be determined at the beginning of each fiscal year within the four year vesting period. In year one of the four-year vesting period, the Company was not able to predict the likelihood of achieving the targets pursuant to the metrics in each of the executives' employment agreements, and therefore no stock compensation expense was recognized for the year ended December 31, 2021.